Crisantaspase

ATC L01XX02 · 5 markets · 10 records

Crisantaspase 5 markets · 10 records Forms

AU 3 records · 2 strengths

  • 20 mg/mLinjectionENRYLAZE recombinant crisantaspase 10 mg/0.5 mL solution for injection/infusion vial unknown
2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名ENRYLAZE ×2ERWINASE ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

GB 2 records · 2 strengths

  • 10 mg/0.5 mLinjectionEnrylaze 10mg/0.5ml solution for injection vials also in FR
1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名Erwinase 10,000unit powder for solution for injection vials ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

FR 2 records · 2 strengths

  • 10 mg/0.5 mLinjectionENRYLAZE 10 mg/0,5 mL, solution injectable/pour perfusion also in GB
  • 10,000 IUinjectionERWINASE 10 000 UI, poudre pour solution injectable/pour perfusion

CA 1 records · 1 strengths

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

    1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商
    With a brand name Con nombre comercial 有商品名 有商品名ENRYLAZE ×2

    Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包

    The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

    Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

    A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.